Antidiabetic and Lipid-Lowering Effects of the Polyphenol Extracts from the Leaves of Clausena lansium (Lour.) Skeels on Streptozotocin-Induced Type 2 Diabetic Rats

Journal of Food Science

Volumn 83, Issue 1, 2018, Pages 212-220

  Kong, Fansheng ^a,b   Su, Zhipeng ^a   Guo, Xiaoming ^b   Zeng, Feng ^c   Bi, Yongguang ^a  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^c FUJIAN AGRICULTURE AND FORESTRY UNIVERSITY   (China)

Author keywords

antidiabetic; lipid lowering; liver protection; polyphenol

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; PLANT EXTRACT; POLYPHENOL; TRIACYLGLYCEROL;

ANIMAL; BLOOD; CHEMISTRY; CHINA; CLAUSENA; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; FRUIT; LIVER; MALE; METABOLISM; PLANT LEAF; RAT; WISTAR RAT;

ANIMALS; CHINA; CHOLESTEROL; CLAUSENA; DIABETES MELLITUS, EXPERIMENTAL; FRUIT; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; LIVER; MALE; PLANT EXTRACTS; PLANT LEAVES; POLYPHENOLS; RATS; RATS, WISTAR; TRIGLYCERIDES;

EID: 85040227278     PISSN: 00221147     EISSN: 17503841     Source Type: Journal    
DOI: 10.1111/1750-3841.14004     Document Type: Article

References (38)

1. Adebajo AC, Iwalewa EO, Obuotor EM, Ibikunle GF, Omisore NO, Adewunmi CO, Obaparusi OO, Klaes M, Adetogun GE, Schmidt TJ, Verspohl EJ. 2009. Pharmacological properties of the extract and some isolated compounds of Clausena lansium stem bark: anti-trichomonal, antidiabetic, anti-inflammatory, hepatoprotective and antioxidant effects. J Ethnopharmacol 122(1):10–9.
2. Ahmed N. 2005. Advanced glycation endproducts—role in pathology of diabetic complications. Diabetes Res Clin Pract 67(1):3–21.
3. Baynes JW. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes 40(4):405–12.
4. Bays HE, Jones PH, Orringer CE, Brown WV, Jacobson TA. 2014. National lipid association annual summary of clinical lipidology 2016. J Clin Lipidol 10(1):S1–S43.
5. Camargo ACD, Biasoto ACT, Shahidi F. 2014. Low molecular weight phenolics of grape juice and winemaking byproducts: antioxidant activities and inhibition of oxidation of human low-density lipoprotein cholesterol and DNA strand breakage. J Agric Food Chem 62(50):12159–71.
6. Chao PC, Cheng CH, Yin MC. 2009. Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice. Nutr Metabol 6(1):33.
7. Chen V, Ianuzzo CD. 1982. Dosage effect of streptozotocin on rat tissue enzyme activities and glycogen concentration. Can J Physiol Pharmacol 60(60):1251–6.
8. Chen XJ, Zhao HG. 2005. Effects of processing Eucommia ulmoides with salt on growth and development and organ coefficient of mice. J Sichuan Tradit Chinese Med 23(11):29–31.
9. de Oliveira LS, Thomé GR, Lopes TF, Reichert KP, de Oliveira JS, Da, SPA, Baldissareli J, Da CKC, Morsch VM, Chitolina SM, Spanevello RM. 2016. Effects of gallic acid on delta-aminolevulinic dehydratase activity and in the biochemical, histological and oxidative stress parameters in the liver and kidney of diabetic rats. Biomed Pharmacother 84:1291–9.
10. Feng YM, Zhao D, Zhang N, Yu CG, Zhang Q, Thijs L, Staessen JA. 2016. Insulin resistance in relation to lipids and inflammation in type-2 diabetic patients and non-diabetic people. PloS One 11(4):e0153171.
11. Fumelli P, Romagnoli F, Carlino G, Fumelii C, Boemi M. 1996. Diabetes mellitus and chronic heart failure. Arch Gerontol Geriatr 23:277–81.
12. Gonzalez-Franquesa A, Burkart AM, Isganaitis E, Patti ME. 2016. What have metabolomics approaches taught us about type 2 diabetes?. Curr Diabet Rep 16(8):1–10.
13. Huang XT, Li YY, Zhang X, Li N. 2014. Effect and mechanism of folium Clausenae lans2 on streptozotocin-induced diabetic rats. Tradit Chinese Drug Res Clin Pharmacol 25(6):651–6.
14. Jiao K, Liu HL, Chen JK, Tian DM, Hou JF, Kaye AD. 2008. Roles of plasma interleukin-6 and tumor necrosis factor-α and FFA and TG in the development of insulin resistance induced by high-fat diet. Cytokine 42(2):161–9.
15. Jin JQ. 2014. Analysis of adverse reactions caused by hypoglycemic agents in 359 cases. Chinese Pharm (10):920–2.
16. Kadoma Y, Fujisawa S. 2008. A comparative study of the radical-scavenging activity of the phenolcarboxylic acids caffeic acid, p-coumaric acid, chlorogenic acid and ferulic acid, with or without 2-mercaptoethanol, a thiol, using the induction period method. Molecules 13(10):2488–99.
17. Kakkar R, Mantha SV, Radhi J, Prasad K, Kalra J. 1998. Increased oxidative stress in rat liver and pancreas during progression of streptozotocin induced diabetes. Clin Sci 94(6):623–32.
18. Li XB, Zhang R, Wang NS, Mi SQ. 2012. Lipid-lowering and hepatoprotective effect of extractsives from folium Clausenae lans2 on nonalcoholic fatty liver rats. Tradit Chinese Drug Res Clin Pharmacol 23(4):405–8.
19. Liu FZ, Song XM, Wang XL, Liu T, Liang RF. 2013. Hypoglycemic effect of total flavones from carambola leaf. Chinese J Exp Tradit Med Formul 19(11):279–81.
20. Liu L, Dan T, Zhao H, Xin X, Aisa HA. 2017. Hypoglycemic effect of the polyphenols rich extract from Rose rugosa Thunb on high fat diet and STZ induced diabetic rats. J Ethnopharmacol 200:174–81.
21. Ma N, Wu K, Huang L. 2008. An elegant synthesis of Zetaclausenamide. Eur J Med Chem 43(4):893–96.
22. Mogensen C. 1989. Natural history of renal functional abnormalities in human diabetes mellitus: from normoalbuminuria to incipient and overt nephropathy. The kidney in diabetes mellitus. New York, N.Y.: Churchill Livingstone. p 19–49.
23. Mohamed AK, Bierhaus, A, Schiekofer S. 1999. The role of oxidative stress and NF (B) activation in late diabetic complications. Biol Factors 10(2-3):175–9.
24. Murphy LO. 1993. Dcct research group, (1993). the effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329(14):977–86.
25. Patel DK, Kumar R, Laloo D, Hemalatha S. 2012. Diabetes mellitus: an overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity. Asian Pac J Trop Biomed 2(05):411–20.
26. Prasad KN, Hao J, Yi C, Zhang D, Qiu S, Jiang Y, Zhang M, Chen F. 2009. Antioxidant and anticancer activities of wampee (Clausena lansium (Lour.) Skeels) peel. J Biomed Biotechnol 2009(1):612805–10.
27. Qi HY, Chai SJ, Deng Z, Zhang XK. 2014. Effect for six kinds of sour- flavor traditional Chinese medicines on oxidative stress and pathological state on liver of diabetic mice. Lishizhen Med Mater Med Res 25(7):1573–5.
28. Rubino F. 2008. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care 31(Suppl 2):S290–6.
29. Rosenblit PD. 2016. Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile? Cardiovasc Diabetol 15(1):1–13.
30. Sharma S, Ali A, Ali J, Sahni JK, Baboota S. 2013. Rutin: therapeutic potential and recent advances in drug delivery. Expert Opin Investig Drugs 22(8):1063–79.
31. Shin SO, Seo HJ, Park H, Song HJ. 2016. Effects of mulberry leaf extracts on blood glucose and serum lipid profiles in patients with type 2 diabetes mellitus: a systematic review. Eur J Integrat Med 8(5):602–8.
32. Thom E. 2007. The effect of chlorogenic acid enriched coffee on glucose absorption in healthy volunteers and its effect on body mass when used long-term in overweight and obese people. J Int Med Res 35(6):900–8.
33. Vicente SJV, Ishimoto EY, Torres EAFS. 2014. Coffee modulatestranscription factor Nrf2 and highly increases the activity of antioxidant enzymes in rats. J Agric Food Chem 62(1):116–22.
34. Wang XB, Ye SD. 2014. The research progress of metformin correlation lactic acidosis. Anhui Med J 35(1):130–3.
35. Willebrords J, Pereira IV, Maes M, Crespo YS, Colle I, Van DBB, de Oliveira CPMS, Cristina DST, Andraus W, Vinken M, Avancini AV, Cogliati B. 2015. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Prog Lipid Res 59:106–25.
36. Yao XM, Duan XC, Wu J, Xie J, Jin X, Gao JR, Wang YZ, Fang ZH, Xia LZ. 2014. Effect of Radix pseudostellariae polysaccharide on blood glucose and lipid metabolism and the influence of renal pathology in diabetic rats. Anhui Med J 18(1):23–26.
37. Zhang ZW, Zhang NN, Shi L, Zhang JM, Bai DD. 2012. Analysis of gradient parameter optimization setting in high performance liquid chromatography. Pract J Med Pharm 29(10):906–07.
38. Zhao W, Li A, Xin F, Hou T, Kang L, Liu B, Zhang N. 2016. Metformin and resveratrol ameliorate muscle insulin resistance through preventing lipolysis and inflammation in hypoxic adipose tissue. Cell Signall 28(9):1401–11.